Aripiprazole (US brand name Abilify® and generic) is a second-generation (atypical) antipsychotic. Here is basic information about this medication.
FDA-approved indications
A. Oral
1. Schizophrenia
2. Acute treatment of manic and mixed episodes associated with bipolar I disorder
3. Adjunctive treatment of major depressive disorder
4. Irritability associated with autistic disorder
5. Treatment of Tourette’s disorder
B. Injectable
Agitation associated with schizophrenia or bipolar mania
Dosage
Schizophrenia (adults)
Initial: 10–15 mg/day
Recommended: 10–15 mg/day
Maximum: 30 mg/day
Schizophrenia (adolescents)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 30 mg/day
Bipolar mania (adults: monotherapy)
Initial: 15 mg/day
Recommended: 15 mg/day
Maximum: 30 mg/day
Bipolar mania (adults: adjunct to lithium or valproate)
Initial: 10–15 mg/day
Recommended: 15 mg/day
Maximum: 30 mg/day
Bipolar mania (pediatric patients: monotherapy or as an adjunct to lithium or valproate)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 30 mg/day
Major depressive disorder (adults: adjunct to antidepressants)
Initial: 2–5 mg/day
Recommended: 5–10 mg/day
Maximum: 15 mg/day
Irritability associated with autistic disorder (pediatric patients)
Initial: 2 mg/day
Recommended: 5–10 mg/day
Maximum: 15 mg/day
Tourette’s disorder (patients <50 kg)
Initial: 2 mg/day
Recommended: 5 mg/day
Maximum: 10 mg/day
Tourette’s disorder (patients >50 kg)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 20 mg/day
Agitation associated with schizophrenia or bipolar mania (adults)
Initial: 9.75 mg/1.3 mL Injected IM
Maximum: 30 mg/day Injected IM
General Instructions:
1. Oral formulations may be administered once daily without regard to meals.
2. IM injection: Wait at least 2 hours between doses. Maximum daily dose 30 mg.
3. In patients who are known CYP2D6 poor metabolizers, prescribe half of the usual dose.
Dosage forms and strengths
Tablets (Abilify® and generic): 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg
Orally disintegrating tablets (Abilify® and generic): 10 mg and 15 mg
Oral solution (generic): 1 mg/mL
Injection (Abilify®): 9.75 mg/1.3 mL single-dose vial (7.5 mg/mL)
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Related Pages
FDA issues new warning about aripiprazole (impulse control problems) (Free)
Aripiprazole (Abilify Maintena®) (Free)
Aripiprazole lauroxil (Aristada®) (Free)
Long-acting injectable antipsychotics (Free)
Second-Generation Antipsychotics: Dose Equivalents
Second-Generation (“Atypical”) Antipsychotics (Free)
Antipsychotics: Index and Links
References
Aripiprazole Prescribing Information
Copyright 2016, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply